This is an exploratory in vitro proof-of-concept study of a novel nanoplatform combining siRNA and photothermal therapy; it demonstrates mechanism in cell models but lacks in vivo efficacy data, clinical translation, or direct comparison to standard antiviral therapy.
Early-stage proof-of-concept study demonstrating a novel nanomaterial's feasibility for tumor imaging in vivo, without comparison to a standard imaging agent or clinical validation.
This is an early-stage preclinical study demonstrating a novel nanozyme design in cell and animal models without clinical translation, efficacy comparators, or human data.
Early-stage in vitro chemical and cellular work demonstrating a novel synthesis and mechanism, lacking animal efficacy data, clinical translation, or comparative trials needed to support therapeutic claims.
Early-stage in vitro work demonstrating proof-of-concept for a nanotheranostic platform in cell models; no animal or clinical data reported, and efficacy claims are based on cultured TNBC cells without in vivo validation or comparative clinical outcomes.
This is an early-stage in vitro study of a novel nanoplatform design using cell lines with no animal or clinical data, demonstrating proof-of-concept for a synthetic construct but lacking the rigor needed to assess clinical utility.